Breaking News
2 hours ago
Mrudula Kulkarni
Simantini Singh Deo
Simantini Singh Deo
Voyager Therapeutics selects VY1706, a tau-silencing gene therapy candidate for Alzheimer’s, with IND filing in 2026.
Simantini Singh Deo
Capricor Therapeutics’ deramiocel gains EMA Orphan Drug and ATMP designations for Duchenne muscular dystrophy.
Simantini Singh Deo
Circio collaborates with Certest Biotec to develop LNP formulations for delivering durable circVec DNA therapies.
Simantini Singh Deo
Conduit Pharmaceuticals appoints Simon Fry to its Board of Directors to enhance growth strategies.
Simantini Singh Deo